October 19, 2012
NHLBI launches program on early cystic fibrosis lung disease
Researchers will study pre-symptomatic lung disease in infants and young children with cystic fibrosis (CF), under a new grant program of the National Heart, Lung, and Blood Institute (NHLBI). Results could reveal how CF develops, which in turn could lead to interventions that delay or prevent disease progression. The studies also could provide critical information to help resolve competing theories on the origin and progression of CF-associated abnormalities
October 10, 2012
NIH grantees win 2012 Nobel Prize in Chemistry
The 2012 Nobel Prize in chemistry has been awarded to National Institutes of Health grantees Robert J. Lefkowitz, M.D., of the Howard Hughes Medical Institute and Duke University Medical Center, Durham, N.C.; and Brian K. Kobilka, M.D., of the Stanford University School of Medicine, Stanford, Calif., for studies of protein receptors that let body cells sense and respond to outside signals.
October 23, 2012
: Miami Herald
Women need to do more to prevent cardiovascular disease
Ana Veciana-Suarez
Women across the country are helping to spread the heart truth about women’s risk of heart disease, but more action is needed to help lower risks and prevent heart disease.
October 22, 2012
: Elsevier Connect
Finding cures for mystery diseases
Len Maniace
NIH researcher and Elsevier editor Neal S. Young honored for solving aplastic anemia and other medical puzzles.
View all NHLBI in the News articles
Reducing the Burden of Sickle Cell Disease
Meeting 26-year old Tiffany McCoy, a bubbly and happy mother, you would never know that she has a serious disease. She is one of about 100,000 Americans with sickle cell disease.
Read full story of success...
International program expands efforts to improve blood transfusion safety
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has launched an $87.2 million international research program to extend a highly successful program assessing blood banking and transfusion medicine. Research conducted under the seven-year program will focus on improving transfusion benefits and reducing its risks
Read full fact sheet...